Springworks Therapeutics Stock Net Income
| SWTXDelisted Stock | USD 46.99 0.00 0.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess SpringWorks Therapeutics' long-term financial health and intrinsic value.
SpringWorks |
SpringWorks Therapeutics Company Net Income Analysis
SpringWorks Therapeutics' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current SpringWorks Therapeutics Net Income | (258.13 M) |
Most of SpringWorks Therapeutics' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SpringWorks Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, SpringWorks Therapeutics reported net income of (258.13 Million). This is 175.64% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 145.21% higher than that of the company.
SpringWorks Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SpringWorks Therapeutics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of SpringWorks Therapeutics could also be used in its relative valuation, which is a method of valuing SpringWorks Therapeutics by comparing valuation metrics of similar companies.SpringWorks Therapeutics is currently under evaluation in net income category among its peers.
SpringWorks Fundamentals
| Return On Equity | -0.52 | ||||
| Return On Asset | -0.28 | ||||
| Profit Margin | (1.16) % | ||||
| Operating Margin | (1.64) % | ||||
| Current Valuation | 3.26 B | ||||
| Shares Outstanding | 75.35 M | ||||
| Shares Owned By Insiders | 1.20 % | ||||
| Shares Owned By Institutions | 87.40 % | ||||
| Number Of Shares Shorted | 6.38 M | ||||
| Price To Earning | 6.14 X | ||||
| Price To Book | 8.49 X | ||||
| Price To Sales | 16.12 X | ||||
| Revenue | 191.59 M | ||||
| Gross Profit | 204.8 M | ||||
| EBITDA | (278.13 M) | ||||
| Net Income | (258.13 M) | ||||
| Cash And Equivalents | 334.54 M | ||||
| Cash Per Share | 6.81 X | ||||
| Total Debt | 7.91 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 9.80 X | ||||
| Book Value Per Share | 5.57 X | ||||
| Cash Flow From Operations | (175.6 M) | ||||
| Short Ratio | 1.46 X | ||||
| Earnings Per Share | (3.41) X | ||||
| Target Price | 47.0 | ||||
| Number Of Employees | 368 | ||||
| Beta | 0.7 | ||||
| Market Capitalization | 3.54 B | ||||
| Total Asset | 587.28 M | ||||
| Retained Earnings | (1.15 B) | ||||
| Working Capital | 280.48 M | ||||
| Current Asset | 29.13 M | ||||
| Current Liabilities | 10.16 M | ||||
| Net Asset | 587.28 M |
About SpringWorks Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SpringWorks Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SpringWorks Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SpringWorks Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in SpringWorks Stock
If you are still planning to invest in SpringWorks Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SpringWorks Therapeutics' history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |